P D Shreve1, M D Gross. 1. Department of Nuclear Medicine, Ann Arbor Veterans Affairs Medical Center, Michigan, USA.
Abstract
UNLABELLED: The purpose of this study was to evaluate [1-11C]-acetate as a tracer for functional imaging of the pancreas and related diseases using position emission tomography (PET). METHODS: Thirty-three patients underwent 30 min of dynamic attenuation-corrected PET after intravenous administration of 740 MBq (20 mCi) of [1-11C]-acetate. RESULTS: The normal pancreas demonstrates prompt uptake of [1-11C]-acetate and is visualized as early as 2 min post-injection, with maximal activity achieved by 5 min. Subsequent clearance of tracer from the pancreas is slow relative to adjacent organs and background, such that by 10 min post-injection the pancreas is the most prominent organ in the imaging field of view. Pancreatic uptake of [1-11C]-acetate was unaffected by pancreatic endocrine insufficiency, but is absent in chronic pancreatitis complicated by exocrine insufficiency. Moderately reduced [1-11C]-acetate uptake was observed in acute uncomplicated pencreatitis. The level of tracer accumulation was substantially reduced in phlegmatous masses complicating pancreatitis and in chronic mass forming pancreatitis. Adenocarcinoma of the pancreas likewise demonstrated no significant uptake of [1-11C]-acetate. CONCLUSIONS: Accumulation of [1-11C]-acetate by the pancreas allows rapid metabolic imaging using PET, and may be a useful metabolic probe for the study of pancreatic physiology and disease.
UNLABELLED: The purpose of this study was to evaluate [1-11C]-acetate as a tracer for functional imaging of the pancreas and related diseases using position emission tomography (PET). METHODS: Thirty-three patients underwent 30 min of dynamic attenuation-corrected PET after intravenous administration of 740 MBq (20 mCi) of [1-11C]-acetate. RESULTS: The normal pancreas demonstrates prompt uptake of [1-11C]-acetate and is visualized as early as 2 min post-injection, with maximal activity achieved by 5 min. Subsequent clearance of tracer from the pancreas is slow relative to adjacent organs and background, such that by 10 min post-injection the pancreas is the most prominent organ in the imaging field of view. Pancreatic uptake of [1-11C]-acetate was unaffected by pancreatic endocrine insufficiency, but is absent in chronic pancreatitis complicated by exocrine insufficiency. Moderately reduced [1-11C]-acetate uptake was observed in acute uncomplicated pencreatitis. The level of tracer accumulation was substantially reduced in phlegmatous masses complicating pancreatitis and in chronic mass forming pancreatitis. Adenocarcinoma of the pancreas likewise demonstrated no significant uptake of [1-11C]-acetate. CONCLUSIONS: Accumulation of [1-11C]-acetate by the pancreas allows rapid metabolic imaging using PET, and may be a useful metabolic probe for the study of pancreatic physiology and disease.
Authors: Astrid A M van der Veldt; Martijn R Meijerink; Alfons J M van den Eertwegh; Epie Boven Journal: Target Oncol Date: 2010-07-14 Impact factor: 4.493
Authors: Norman Ray Simpson; Fabiola Souza; Piotr Witkowski; Antonella Maffei; Anthony Raffo; Alan Herron; Michael Kilbourn; Agata Jurewicz; Kevan Herold; Eric Liu; Mark Adam Hardy; Ronald Van Heertum; Paul Emerson Harris Journal: Nucl Med Biol Date: 2006-10 Impact factor: 2.408
Authors: Fabiola Souza; Norman Simpson; Anthony Raffo; Chitra Saxena; Antonella Maffei; Mark Hardy; Michael Kilbourn; Robin Goland; Rudolph Leibel; J John Mann; Ronald Van Heertum; Paul E Harris Journal: J Clin Invest Date: 2006-05-18 Impact factor: 14.808